A regulatory filing disclosed that Mark Chiplock, Executive Vice President, Chief Financial Officer, and Chief Administrative Officer of Ameresco, Inc. (NASDAQ:AMRC), disposed of 476 shares of Class A Common Stock on September 15, 2026, at a price of $22.46 per share, for total proceeds of $10,690.
The transaction was carried out pursuant to an automatic sell-to-cover instruction originally signed on March 7, 2023. This type of pre-arranged plan is designed solely to cover applicable withholding taxes associated with the vesting of restricted stock units, and the sale does not represent a discretionary trade by the executive.
Following the transaction, Mr. Chiplock directly holds 2,815 shares of Ameresco Class A Common Stock.
Since the sale date, Ameresco's stock has risen to $26.51, marking a 38% gain over the past week. Such price action is consistent with the stock's beta of 2.51, which indicates higher volatility relative to the broader market. Market participants often monitor insider filings for signals about management's confidence, but in this case the sale was tied to a pre-existing tax obligation rather than an active investment decision.
In other recent developments, Ameresco reported third-quarter 2026 financial results that exceeded Wall Street expectations. The company delivered non-GAAP earnings of $0.88 per share, well above the anticipated $0.57, and generated revenue of $580.31 million, slightly ahead of the forecasted $572.85 million. Gross margin improved to 18.7%, and the company's backlog increased to nearly $7.2 billion, underscoring strong operational performance and a robust pipeline of future work.
Additionally, Stifel revised its price target for Ameresco to $37 from $38 while maintaining a Buy rating. The adjustment followed the company's record backlog and unchanged operational outlook for 2026. Stifel's continued positive stance reflects confidence in Ameresco's strategic direction and market position.
These recent developments provide investors with valuable insights into Ameresco's financial health and market trajectory.